Business Wire

LUOHAN-ACADEMY

24.1.2019 15:10:10 CET | Business Wire | Press release

Share
Luohan Academy Unveils Report on Digital Technology and Inclusive Growth at World Economic Forum

Luohan Academy – an open research institute initiated by Alibaba Group Holding Limited (NYSE: BABA) – today released its first report examining the oft-debated relationship between digital technology and economic growth at the 2019 World Economic Forum in Davos. The report demonstrates how digital technology can drive inclusive growth in ways previous technology revolutions have not, especially when policies and public-private sector cooperation are supportive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190124005445/en/

The report was launched at an event co-hosted with the World Bank, and featured speeches and discussions with high-profile experts, including Her Majesty Queen Máxima of the Netherlands and the UN Secretary-General's Special Advocate for Inclusive Finance for Development (UNSGSA); Kristalina Georgieva, CEO of the World Bank; Michael Spence, Professor of Economics at New York University and Nobel Prize Winner; Jack Ma, Alibaba Group Executive Chairman; and Chen Long, Director of Luohan Academy. More than 120 delegates from the World Economic Forum attended the launch event, including government officials, chief executives, academics, and heads of NGOs, international organizations and development agencies.

The report “Digital Technology and Inclusive Growth ” details why the benefits of the current digital revolution can be more evenly distributed than they were in previous technological revolutions. At the macro level, widespread adoption and application of digital technology is no longer dependent on level of income and economic development. At the micro level, digital technology is making it easier for consumers to start businesses, reach consumers, and access financing. Using China as a case study, the report illustrates how digital technologies can provide more access to economic opportunity in ways not possible previously.

“Experience in China and other emerging markets shows the tremendous potential of a new growth path, one that makes development more inclusive and sustainable,” said Chen Long, Director of Luohan Academy. “With public-private joint efforts and the right policies, the digital age presents new opportunities for emerging markets that did not exist before.”

This report identifies where digital technologies have made a material difference for inclusive growth in China, and offers some insights on how to apply the lessons learned in China to other markets. Some key findings include:

  • Lowering the skill threshold: In order to promote digital penetration, lowering the skill threshold needed to use technology is as important as raising the level of technological expertise. For example, in rural Taobao villages in China, e-tailer households that participate in e-commerce earn more than double the income of non-e-tailer households at every education level because the skills can be learned on the job; no formal education required.
  • Leveraging digital platforms: Digital platforms represent a new form of exchange and coordination to create an ecosystem for inclusive growth. It is a free-spinning wheel that connects numerous consumers and producers, and facilities interactions with very low cost, high efficiency, and reliability.
  • Forming effective public-private partnerships: It is more important than ever for the public sector to create a benign macro environment for the private sector to grow and make necessary investments for the population to access digital technology.
  • Managing unanticipated effects: In the digital age, there have been concerns about real and complex issues such as technological unemployment, abuse of private information, lagging competition policy, and increased inequality. The first step to address these challenges is to separate facts from speculation and anxiety. The evidence in China shows that the benefits of new market access and opportunities are more pronounced in less developed countries.

“This report on digitally enabled growth patterns in China is very interesting. The data shows that the mobile internet, e-commerce, mobile payments and internet-based financial services together have accelerated overall growth and produced startlingly inclusive growth patterns in multiple dimensions. The report documents this, and explains why these effects occur,” said Michael Spence, 2001 Nobel Prize Laureate in Economics and professor at New York University. “In conjunction with gained experience in other developing countries, there is a very convincing case that digitally-enabled, platform-based ecosystems are a new and powerful growth engine.”

Launched in June 2018 in Hangzhou, the Luohan Academy is focused on addressing universal challenges that arise from the rapid development of digital technologies. With 16 Nobel Prize laureates and prominent academics as committee members, the institute aims at bringing together the top scholars in the world to study the most pressing issues of the digital economy and advance the research of technology and its impact on humanity.

About Luohan Academy

Luohan Academy, an independent think tank and open research institute, was initiated by Alibaba Group on 26th June, 2018 in Hangzhou, China. It was launched by Jack Ma, Alibaba's founder and Executive Chairman, and 16 academic committee members. Luohan Academy intends to bring together the best thinkers in the world with first-hand practical insights into the digital economy in order to advance the research frontiers of digital technology and its impact on humanity. Its mission is two-fold: to understand how digital technology can help achieve common good; and to build a broad research community for systematic and in-depth learning, leading to new paradigms for solving the most pressing issues in digital society.

Contact:

Media: Holly Zhao Holly.zhao@alibaba-inc.com +1 (505) 469-3316

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye